Based at UC San Diego, ADCS is an NIH-funded national consortium of Alzheimer's disease researchers conducting AD clinical trials throughout U.S. and Canada.
Raising Thiamine Levels in the Brain to Treat Early Alzheimer’s Disease Dr. Jose Luchsinger Benfo Team on the Empowered Patient Podcast with Karen Jagoda
empoweredpatientradio.com/ra…
ALT Peter Lucchini and his wife are seated on a sofa being interviewed in a professional studio setting with cameras, lights, and a production crew.
ALT Dr. Gabriel Leger and an interviewer in a television studio setup, seated in armchairs facing each other, with cameras, lights, and a backdrop of a room with large windows.
We invite you to join the Shiley-Marcos Alzheimer’s Disease Research Center for the Shiley Endowed Lecture on February 1st at 9 am, in ACTRI Auditorium. More information in flyer below and please RSVP here: ucsd.co1.qualtrics.com/jfe/f…
Come to San Diego! To lead our nationally recognized aging institute! See link here - deadline for applications is June 15, 2023. Reach out with any questions and RT! apol-recruit.ucsd.edu/JPF035…
We vow to help end the devastation caused by dementia, with dedicated support and life-changing treatments.
Together we are help and hope for everyone living with dementia.
Find more information at bit.ly/theultimatevowtwitter.
Attending @CAR_Karolinska webinar on sex differences in Alzheimer. The great @bucklr01 is taking us on a journey, highlighting current understanding and open questions, especially on tau biology.
Objective sleep variability from accelerometry, amyloid PET burden, and cognition, a new pub by Laura Fenton @laurafenton91 and via the committed data collection of many! academic.oup.com/braincomms/…
Latest from the lab: we used the polygenic hazard score to model a way to recruit efficiently for AD trials 🧠🧬🥼with tau or cog outcomes, led by Xin Wang: alz-journals.onlinelibrary.w…
Been waiting for a paper like this to come out! From Dr Josh Grill's lab @UCIrvine. Female % in #Alzheimer clinical trials = well represented. But some demog imbalances at bl. Should have power to investigate treatment effects, IMO. Great study!
doi.org/10.1002/alz.066031
Dr. Emily Rogalsksi (@ERogalskiPhD), Associate Director of the Mesulam Center, appeared on the November 28 edition of @CNNThisMorning to discuss the Northwestern SuperAging Research Program.
youtu.be/ceCnHMUzASQ
Clinical neuropsychology postdoc available in Alzheimer’s/imaging/sex diffs/modifiable risk details here: neurosciences.ucsd.edu/resea… feel free to email and please retweet! Pic 10 mins from the office! 🧠🧠🧠🐬
Positive study results in the Alzheimer's drug lecanemab were released this week. Dr. Judy Pa, Co-Director of the Alzheimer's Disease Cooperative Study @PaLab_UCSD , spoke to KNX about what the results mean for Alzheimer's research. bit.ly/3BPqz2S#Alzheimers#lecanemab
Stop by booth 1015 and meet our co-directors Dr. Howard Feldman and Dr. Judy Pa @PaLab_UCSD between 3:30 pm and 4:15 pm to learn about our current and future clinical trials. #AAIC2022